A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. (2023)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01841-4
PubMed Identifier: 36739136
Publication URI: http://europepmc.org/abstract/MED/36739136
Type: Journal Article/Review
Volume: 401
Parent Publication: Lancet (London, England)
Issue: 10374
ISSN: 0140-6736